Literature DB >> 9080610

p53 and tumour viruses: catching the guardian off-guard.

J C Neil1, E R Cameron, E W Baxter.   

Abstract

Oncogenic viruses have evolved direct and indirect mechanisms to overcome the tumour suppressor p53. Fortunately, tumour development is limited by the narrow cell tropisms of the viruses concerned and the host immune response. However, such viruses are helping to elucidate the p53 response pathway and may play a future role as novel cancer therapeutic agents.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9080610     DOI： 10.1016/S0966-842X(96)10083-4

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  10 in total

1.  Clink, a nanovirus-encoded protein, binds both pRB and SKP1.

Authors:  M N Aronson; A D Meyer; J Györgyey; L Katul; H J Vetten; B Gronenborn; T Timchenko
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Antiviral action of the tumor suppressor ARF.

Authors:  María A García; Manuel Collado; César Muñoz-Fontela; Ander Matheu; Laura Marcos-Villar; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

4.  Measles virus V protein inhibits p53 family member p73.

Authors:  Cristian D Cruz; Heidi Palosaari; Jean-Patrick Parisien; Patricia Devaux; Roberto Cattaneo; Toru Ouchi; Curt M Horvath
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations.

Authors:  R K Brachmann; K Yu; Y Eby; N P Pavletich; J D Boeke
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.

Authors:  J C Mulloy; T Kislyakova; A Cereseto; L Casareto; A LoMonico; J Fullen; M V Lorenzi; A Cara; C Nicot; C Giam; G Franchini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.

Authors:  Young C Shin; Hiroyuki Nakamura; Xiaozhen Liang; Pinghui Feng; Heesoon Chang; Timothy F Kowalik; Jae U Jung
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.

Authors:  Alexander V Kofman; Christopher Letson; Evan Dupart; Yongde Bao; William W Newcomb; David Schiff; Jay Brown; Roger Abounader
Journal:  Med Hypotheses       Date:  2013-05-02       Impact factor: 1.538

9.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12

10.  Contributory role of viral infection in congenital tumour development.

Authors:  Maryam Monajemzadeh; Soheila Sarmadi; Maryam Moeini; Mohammad Vasei; Nima Rezaei; Ata Abbasi; Reza Shahsiah; Parin Tanzifi; Maryam Eghbali
Journal:  Ecancermedicalscience       Date:  2013-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.